Table 2.
Morphometric characteristics of erythrocytes from apparently healthy people and from patients with SA and MI before and after treatment, n = 20 (М ± SD).
| Test groups | Indices | |||
|---|---|---|---|---|
| The mean value of optical path difference (OPD), Φmean, nm | Phase image area of erythrocyte, S, µm2 | Geometric mean height of the erythrocyte, Z, µm | Erythrocyte phase volume, V, µm3 | |
| Control | 151.82 ± 6.46 | 43.43 ± 3.79 | 2.02 ± 0.11 | 87.73 ± 4.82 |
| SA patients before treatment | 177.39 ± 5.39∗ | 40.80 ± 3.30 | 2.36 ± 0.14∗ | 96.29 ± 3.55∗ |
| SA patients after treatment | 115.38 ± 4.61∗Δ | 55.99 ± 2.93∗Δ | 1.53 ± 0.11∗Δ | 75.59 ± 3.99∗Δ |
| MI patients before treatment | 187.53 ± 6.41∗ | 40.66 ± 2.90 | 2.50 ± 0.15∗ | 101.65 ± 2.98∗ |
| MI patients after treatment | 114.39 ± 3.82∗Δ | 59.40 ± 2.25Δ | 1.52 ± 0.14∗Δ | 74.25 ± 4.46Δ |
∗ p < 0.05, reliability in relation to donors' indicators; Δp < 0.05, reliability in relation to pretreatment indicators.